期刊文献+

腹膜后恶性肿瘤的外科治疗 被引量:2

原文传递
导出
摘要 原发性腹膜后肿瘤(PRT)是指起源于腹膜后潜在腔隙,并除外起源胰、肾、肾上腺、血管等的肿瘤。该病可发生于任何年龄,高发年龄为50~60岁,男性发病略多于女性。PRT发病率较低,仅占全身肿瘤的0.07%~0.20%,约60%~85%为恶性腹膜后肿瘤(MPRT)。
作者 吴泽宇 彭林
出处 《中华疝和腹壁外科杂志(电子版)》 2011年第1期11-13,共3页 Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition)
  • 相关文献

参考文献10

  • 1孙跃民,王成锋,田艳涛,赵东兵,单毅,赵平.原发性腹膜后恶性肿瘤的外科治疗与预后分析[J].中华医学杂志,2009,89(38):2699-2701. 被引量:11
  • 2陈文卫,罗和生,徐英,张玉国,刘勤,盛余敬,付文谨,孙彬,陈孝义,赫杰,郑勇斌.腹膜后良恶性肿瘤的超声造影初步研究[J].中华超声影像学杂志,2008,17(12):1057-1060. 被引量:5
  • 3乔明洲,李长岭.腹膜后软组织肉瘤术后复发分析[J].中华医学杂志,2007,87(36):2547-2548. 被引量:4
  • 4Avancès C,Mottet N,Mahatmat A,et al.Prognostic factors for first recurrence in patients with retroperitoneal sarcoma.Urol Oncol,2006,24:94-96.
  • 5Stojadinovic A,Leung DH,Hoos A,et al.Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.Ann Surg,2002,235:424-434.
  • 6Marinello P,Montresor E,Iacono C,et al.Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas.Chir Ital,2001,53:149-157.
  • 7许元鸿,郭克建,马明辉,白岩,于国志,葛春林,郭仁宣,李良庚,田雨霖,何三光.98例成人原发性腹膜后恶性肿瘤的诊治分析[J].中华外科杂志,2007,45(11):756-758. 被引量:6
  • 8Lewis JJ,Leung D,Woodruff JM,et al.Retroperitoneal soft-tissue sarcoma:analysis of 500 patients treated and followed at a single institution.Ann Surg,1998,228:355-365.
  • 9Erzen D,Sencar M,Novak J.Retroperitoneal sarcoma:25 years of experience with aggressive surgical treatment at the institute of oncology,Ljubljana.J Surg Oncol,2005,91:1-9.
  • 10Errario T,Karakousis CP.Retroperitoneal sarcomas:grade and survival.Arch Surg,2003,138:248-251.

二级参考文献22

  • 1覃谦,施开德,庄晓泉,李洪,王力斌,李君久,陈顺文.原发性腹膜后肿瘤的诊断与外科治疗[J].中华普通外科杂志,2005,20(1):33-35. 被引量:14
  • 2陈春球,尹路,彭承宏,赵任,李宏为.原发性腹膜后肿瘤107例治疗与预后分析[J].中国实用外科杂志,2006,26(11):850-851. 被引量:12
  • 3Yuan-Hong Xu Ke-Jian Guo R.en-Xuan Guo Chun-Lin Ge Yu-Lin Tian San-Guang He.Surgical management of 143 patients with adult primary retroperitoneal tumor[J].World Journal of Gastroenterology,2007,13(18):2619-2621. 被引量:12
  • 4Correas JM,Bridal L, Lesavre A, et al. Ultrasound contrast agents; properties,principles of action, teloerance and artifact. Eur Radiol, 2001,11 :1316-1328.
  • 5Albrecht T, Oldenburg A, Hohmann J, et al. Imaging of liver metastases with contrast-specific low MI real-time ultrasound and SonoVue. Eur Radiol, 2003,13 (suppl 3) : N79-86.
  • 6Strobel D, Krodel J, Martus P,et al. Clinical evaluation of contrast enhanced color Doppler sonography in the differential diagnosis of liver tumor. J Clin Ultrasound, 2000,28 : 1-13.
  • 7Orden MR, Jurvelin JS, Kirkinen PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology, 2003, 226:405-410.
  • 8Merrt H, Sauget S, Giraudeau B, et al. Contrast enhanced sonography helps discrimination of benign from malignant adnexal masses. J Ultrasound Med, 2004,23: 1629-1639.
  • 9Serio G, Tenchini P, Nifosi F, et al. Surgical strategy in primary retroperitoneal tumours. Br J Surg, 1989, 76:385-389.
  • 10Jenkins MP, Alvaranga JC, Thomas JM. The management of retroperitoneal soft tissue sarcomas. Eur J Cancer, 1996, 32A: 622-629.

共引文献21

同被引文献19

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部